MICHAEL MCDONALD: Open Payments
NPI 1265413793 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 26 payments from 11 companies in 2025. Trend: 2023 $1,110 · 2024 $467 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $178 |
| Ardelyx, Inc. | 3 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Novo Nordisk Inc | 2 | $43 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: IBSRELA, RINVOQ, XIFAXAN, SKYRIZI, REZDIFFRA, Wegovy, ZENPEP, ENTYVIO.
Industry payments across CT — which companies pay providers there.
